Role of intestinal microbiome in American ginseng-mediated colon cancer protection in high fat diet-fed AOM/DSS mice
- 14 August 2017
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 20 (3) , 302-312
Abstract
Objective Chronic intestinal inflammation is a risk factor for colorectal cancer (CRC) initiation and development. Diets that are rich in Western style fats have been shown to promote CRC. This study was conducted to investigate the role of intestinal microbiome in American ginseng-mediated CRC chemoprevention in a mouse model. The population and diversity of enteric microbiome were evaluated after the ginseng treatment. Methods Using an azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced gut inflammation and tumorigenesis mouse model, the effects of oral American ginseng on high fat diet-associated enteric pathology were determined. After establishment of a 16S rRNA illumina library from fecal samples, MiSeq sequencing was carried out to reveal the microbial population. The alpha and beta diversities of microbiome were analyzed. Results American ginseng significantly attenuated AOM/DSS-induced colon inflammation and tumorigenesis by reducing the colitis score and colon tumor multiplicity. The MiSeq results showed that the majority of sequences fell into three phyla: Firmicutes, Bacteroidetes and Verrucomicrobia. Further, two significant abundance shifts at the family level, Bacteroidaceae and Porphyromonadaceae, were identified to support ginseng’s anti-colitis and anti-tumor effects. In addition, alpha and beta diversity data demonstrated that ginseng led to a profound recovery from the AOM/DSS-induced dysbiosis in the microbial community. Conclusion Our results suggest that the CRC chemopreventive effects of American ginseng are mediated through enteric microbiome population-shift recovery and dysbiosis restoration. Ginseng’s regulation of the microbiome balance contributes to the maintenance of enteric homeostasis.Keywords
Funding Information
- National Center for Complementary and Alternative Medicine (AT004418, AT005362)
- National Cancer Institute (GM120046)
- National Institute of Diabetes and Digestive and Kidney Diseases (5P30DK042086)
This publication has 30 references indexed in Scilit:
- The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequencesBMC Bioinformatics, 2012
- Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancerInternational Journal of Oncology, 2012
- American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFRBMC Complementary and Alternative Medicine, 2011
- Ginsenosides from American ginseng: Chemical and pharmacological diversityPhytochemistry, 2011
- The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studiesJournal of Carcinogenesis, 2011
- Gut Microbiota in Health and DiseasePhysiological Reviews, 2010
- 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitisThe ISME Journal, 2009
- Red American Ginseng: Ginsenoside Constituents and Antiproliferative Activities of Heat-Processed Panax quinquefolius RootsPlanta Medica, 2007
- Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instabilityOncogene, 2004
- Diet and CancerThe Oncologist, 2000